Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
Pluristem Therapeutics reports 2019 executive compensation
By ExecPay News
Published: May 20, 2020
Pluristem Therapeutics reported fiscal year 2019 executive compensation information on May 20, 2020.
In 2019, four executives at Pluristem Therapeutics received on average a compensation package of $628K, a 38% increase compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chairman, received $1.1M in total, which increased by 85% compared to 2018. 50% of Aberman's compensation, or $551K, was in salary. Aberman also received $479K in stock awards and $67K in other compensation.
Yaky Yanay, Chief Executive Officer, received a compensation package of $887K, which increased by 100% compared to previous year. 52% of the compensation package, or $461K, was in stock awards.
Erez Egozi, Chief Financial Officer, earned $325K in 2019, which is about the same as previous year.
Chen Franco-Yehuda, Chief Financial Officer, received $205K in 2019.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on May 20, 2020.